The overall market for chronic pain therapies is predicted to remain stable at approximately $20 billion. Chronic back pain and arthritis pain together account for nearly 57 percent of the overall chronic pain drug market in 2010. The report also found pain physicians are skeptical the government-mandated Risk Evaluation and Mitigation Strategy programs will change physician prescribing habits.
Related Articles on Pain Management:
Dr. Andrew C. Charles Named First Luskin Chair in Migraine and Headache Studies at UCLA
Global Anesthesia Disposables Market to Reach $343.5M by 2017
DSM Collaborates with AdeTherapeutics to Develop Pain Management and Scar Reduction Product for Spine Surgeries
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.